Andrew Scott is an associate in the Capital Markets practice in London. Andrew helps clients access equity capital markets through a wide range of transactions including initial public offerings and secondary fundraisings on the London Stock Exchange. Andrew also regularly advises on listing rules, market abuse regulation and corporate governance matters.
Prior to joining White & Case, Andrew worked at Magic Circle and international firms in London and Hong Kong.
Just Eat Takeaway, 2020*
Advised Bank of America, as sponsor to Takeaway.com, on its merger with Just Eat and premium listing on the LSE.
Helios Towers, 2019*
Advised Newlight Partners, as selling shareholder, on Helios Towers’ £1.15 billion IPO and premium listing on the LSE.
Future, 2018 – 2019*
Advised Future on its £106 million rights issue and acquisition of Purch’s business-to-consumer business, its transfer from the standard to the premium listing segment of the Official List and its £104 million cash box placing and £140 million class 1 acquisition of TI Media.
Provident Financial, 2018*
Advised Barclays and J.P. Morgan on Provident Financial’s £331 million rights issue.
Advised J.P. Morgan, Numis and Rothschild on Laird’s £185 million rights issue.
Advised the consortium of banks led by Barclays and Bank of America Merrill Lynch on Informa’s £715 million rights issue and class 1 acquisition of Penton Information Services.
McCarthy & Stone, 2015*
Advised Deutsche Bank, Goldman Sachs, Jefferies and Peel Hunt on McCarthy & Stone’s £967 million IPO and premium listing on the LSE.
BBA Aviation, 2015*
Advised the consortium of banks led by J.P. Morgan and Jefferies on BBA Aviation’s £748 million rights issue and class 1 acquisition of Landmark Aviation.
Advised the consortium of banks led by Bank of America Merrill Lynch and J.P. Morgan on Serco’s £555 million rights issue.
Virgin Money, 2014*
Advised the consortium of banks led by Goldman Sachs and Bank of America Merrill Lynch on Virgin Money’s £1.25 billion IPO and premium listing on the LSE.
Spire Healthcare, 2014*
Advised Spire Healthcare on its £842 million IPO and premium listing on the LSE and post-IPO corporate governance matters.